Shareholder Votes

REVELATION BIOSCIENCES, INC. shareholders approved Ratification of Baker Tilly US, LLP as auditor for fiscal year ending December 31, 2024 at the 2024-12-31 meeting.

“Stockholders ratified Baker Tilly US, LLP to audit our financial statements for the fiscal year ending December 31, 2024, based on the votes listed below: For Against Abstain 595,879 18,558 258 There were no broker non-votes regarding this proposal.”

REVELATION BIOSCIENCES, INC. shareholders approved Approval to increase the number of shares reserved under the Company's 2021 Equity Incentive Plan from 21,623 to 163,294.

“Stockholders approved an amendment to the 2021 Equity Incentive Plan to increase the number of shares reserved under the 2021 Equity Incentive Plan from 21,623 to 163,294, based on the votes listed below: For Against Abstain 107,447 42,981 2,729 There were 461,538 broker non-votes regarding this proposal.”

REVELATION BIOSCIENCES, INC. shareholders approved Election of two nominees for Class B director: James Rolke and Jess Roper.

“Stockholders approved to elect the two nominees for Class B director named herein to serve until the 2027 Annual Meeting or their successors are duly elected and qualified, based on the votes listed below: Director Nominee For Against Abstain James Rolke 122,822 23,715 6,620 Jess Roper 122,543 27,978 2,636 There were 461,538 broker non-votes regarding the election of directors.”

PROG Holdings, Inc. shareholders approved Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2024 at the 2024-05-15 meeting.

“Proposal 3 – Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2024 For Against Abstain Non-Votes 38,893,623 2,064,287 132,210 —”

PROG Holdings, Inc. shareholders approved Approval of a non-binding resolution to approve the Company's executive compensation at the 2024-05-15 meeting.

“Proposal 2 – Approval of a non-binding resolution to approve the Company’s executive compensation For Against Abstain Non-Votes 36,048,569 2,414,608 131,770 2,495,173”

PROG Holdings, Inc. shareholders approved Election of directors at the 2024-05-15 meeting.

“Proposal 1 – Election of directors For Against Abstain Non-Votes Kathy T. Betty 36,869,205 1,705,144 20,598 2,495,173”

Assure Holdings Corp. shareholders approved Amendment to the Company's Articles of Incorporation to increase authorized shares of common stock from 9,000,000 to 250,000,000 at the 2024-05-14 meeting.

“Proposal One– Authorized Share Increase By a resolution passed, the stockholders approved an amendment to the Company’s Articles of Incorporation to increase the Company’s authorized shares of common stock from 9,000,000 to 250,000,000. Votes FOR Votes AGAINST Votes ABSTAIN Broker Non-Votes 5,226,969 194,592 5,901 0”

Richmond Mutual Bancorporation, Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2024-05-15 meeting.

“Proposal 2 - Ratification of Appointment of Independent Registered Public Accounting Firm The Company’s shareholders approved the ratification of the appointment of FORVIS, LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2024. Number of Votes For 8,418,872 Against 30,392 Abstain 75,612”

Richmond Mutual Bancorporation, Inc. shareholders approved Election of Directors at the 2024-05-15 meeting.

“Proposal 1 - Election of Directors The Company’s shareholders approved the election of Jeffrey A. Jackson and M. Lynn Wetzel as directors of the Company each for a three-year term to expire in the year 2027. For Withheld Broker Non-Vote Jeffrey A. Jackson 4,728,317 1,848,695 1,947,864 M. Lynn Wetzel 4,733,505 1,843,507 1,947,864”

Angel Oak Mortgage REIT, Inc. shareholders approved Non-binding advisory vote on the compensation of the Company's named executive officers at the 2024-05-15 meeting.

“For the approval, on a non-binding, advisory basis, a resolution regarding the compensation of the Company’s named executive officers: Number of Votes For Number of Votes Against Abstentions Broker Non-Votes 18,393,452 1,992,669 43,294 2,088,500”

Angel Oak Mortgage REIT, Inc. shareholders approved Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024 at the 2024-05-15 meeting.

“For the ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2024: Number of Votes For Number of Votes Against Abstentions 22,480,487 27,059 10,369”

Angel Oak Mortgage REIT, Inc. shareholders approved Election of eight directors to serve until the 2025 Annual Meeting at the 2024-05-15 meeting.

“On May 15, 2024, Angel Oak Mortgage REIT, Inc. (the “Company”) held its Annual Meeting of Stockholders (the “2024 Annual Meeting”) to (i) elect the eight (8) directors listed below, each to serve until the Company’s 2025 Annual Meeting of Stockholders and until their successors are duly elected and qualify; and (ii) ratify the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2024.”

BICYCLE THERAPEUTICS PLC shareholders approved To adopt the new articles of association in substitution for, and to the exclusion of, the Company's existing articles of association. at the 2024-05-16 meeting.

“Proposal 11 – To adopt the new articles of association in substitution for, and to the exclusion of, the Company’s existing articles of association. For Against Vote Withheld/Abstain 37,371,711 15,138 11,258”

BICYCLE THERAPEUTICS PLC shareholders approved To authorize the Board to allot equity securities for cash up to a maximum aggregate nominal amount of £1,000,000 pursuant to the authorization in Resolution 9 as if U.K. statutory pre-emption rights did not apply. at the 2024-05-16 meeting.

“Proposal 10 – To authorize the Board to allot equity securities for cash up to a maximum aggregate nominal amount of £1,000,000 pursuant to the authorization in Resolution 9 as if U.K. statutory pre-emption rights did not apply. For Against Vote Withheld/Abstain 32,350,797 4,154,715 892,595”

BICYCLE THERAPEUTICS PLC shareholders approved To authorize the Board to allot shares in the Company or to grant rights to subscribe for or to convert any security into shares in the Company up to a maximum aggregate nominal amount of £1,000,000. at the 2024-05-16 meeting.

“Proposal 9 – To authorize the Board to allot shares in the Company or to grant rights to subscribe for or to convert any security into shares in the Company up to a maximum aggregate nominal amount of £1,000,000. For Against Vote Withheld/Abstain 33,241,556 4,146,578 9,973”

BICYCLE THERAPEUTICS PLC shareholders approved To approve the directors' remuneration report for the year ended December 31, 2023. at the 2024-05-16 meeting.

“Proposal 8 – To approve the directors’ remuneration report for the year ended December 31, 2023. For Against Vote Withheld/Abstain 36,200,790 1,188,057 9,260”

BICYCLE THERAPEUTICS PLC shareholders approved To receive and adopt the Company's U.K. statutory annual accounts and reports for the year ended December 31, 2023. at the 2024-05-16 meeting.

“Proposal 7 – To receive and adopt the Company’s U.K. statutory annual accounts and reports for the year ended December 31, 2023. For Against Vote Withheld/Abstain 36,494,043 896,166 7,898”

BICYCLE THERAPEUTICS PLC shareholders approved To authorize the Audit Committee of the Company's Board of Directors to determine the Company's U.K. statutory auditors' remuneration for the year ending December 31, 2024. at the 2024-05-16 meeting.

“Proposal 6 – To authorize the Audit Committee of the Company’s Board of Directors (the “Board”) to determine the Company’s U.K. statutory auditors’ remuneration for the year ending December 31, 2024. For Against Vote Withheld/Abstain 37,376,455 14,150 7,502”

BICYCLE THERAPEUTICS PLC shareholders approved To re-appoint PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as the Company's U.K. statutory auditors, to hold office until the conclusion of the next annual general meeting of shareholders. at the 2024-05-16 meeting.

“Proposal 5 – To re-appoint PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as the Company’s U.K. statutory auditors, to hold office until the conclusion of the next annual general meeting of shareholders. For Against Vote Withheld/Abstain 37,376,531 14,071 7,505”

BICYCLE THERAPEUTICS PLC shareholders approved To ratify the appointment of PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as the Company's U.S. independent registered public accounting firm for the year ending December 31, 2024. at the 2024-05-16 meeting.

“Proposal 4 – To ratify the appointment of PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as the Company’s U.S. independent registered public accounting firm for the year ending December 31, 2024. For Against Vote Withheld/Abstain 37,376,526 14,076 7,505”

BICYCLE THERAPEUTICS PLC shareholders approved To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's definitive proxy statement. at the 2024-05-16 meeting.

“Proposal 3 – To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in the Company’s definitive proxy statement. For Against Vote Withheld/Abstain 36,186,115 1,202,477 9,515”

BICYCLE THERAPEUTICS PLC shareholders approved To re-elect as a director Jose-Carlos Gutierrez-Ramos. at the 2024-05-16 meeting.

“Proposal 2 – To re-elect as a director Jose-Carlos Gutierrez-Ramos. For Against Vote Withheld/Abstain 35,019,069 2,371,385 7,653”

BICYCLE THERAPEUTICS PLC shareholders approved To re-elect as a director Kevin Lee. at the 2024-05-16 meeting.

“Proposal 1 – To re-elect as a director Kevin Lee. For Against Vote Withheld/Abstain 36,413,260 977,286 7,561”

MetroCity Bankshares, Inc. shareholders approved Proposal 2 – Ratification of Auditors: To ratify the appointment of Crowe LLP as the Company’s independent registered public accounting firm for the year ended December 31, 2024. at the 2024-05-16 meeting.

“Votes For ​ Votes Against ​ Abstentions ​ Broker Non-Votes 21,196,112 ​ 52,219 ​ 615 ​ —”

MetroCity Bankshares, Inc. shareholders approved Proposal 1 – Election of Directors: To elect three (3) incumbent Class III directors named in the proxy statement to serve until the 2027 Annual Meeting of Shareholders. at the 2024-05-16 meeting.

“The final results of each of the proposals voted on by the Company’s shareholders are described below: Proposal 1 – Election of Directors: To elect three (3) incumbent Class III directors named in the proxy statement to serve until the 2027 Annual Meeting of Shareholders.”

BrightSpire Capital, Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2024-05-16 meeting.

“Proposal 3 — Ratification of Appointment of Independent Registered Public Accounting Firm The Company’s stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024, by the following vote: For Against Abstentions Broker Non-Votes 96,821,072 810,429 188,362 0”

BrightSpire Capital, Inc. shareholders approved Approval (on an advisory, non-binding basis) of Executive Compensation at the 2024-05-16 meeting.

“Proposal 2 — Approval (on an advisory, non-binding basis) of Executive Compensation The Company’s stockholders approved (on an advisory, non-binding basis) the compensation of the Company’s named executive officers as of December 31, 2023 as described in the Compensation Discussion and Analysis and executive compensation tables of the proxy statement for the Annual Meeting. The table below sets forth the voting results for this proposal: For Against Abstentions Broker Non-Votes 69,370,153 2,207,450 889,452 25,352,808”

BrightSpire Capital, Inc. shareholders approved Election of Directors at the 2024-05-16 meeting.

“Proposal 1 — Election of Directors The following persons comprising the entire Board of Directors of the Company were duly elected as directors of the Company to serve until the Company’s 2025 annual meeting of stockholders and until his or her successor is duly elected and qualified, by the following vote: Nominee For Withheld Abstentions Broker Non-Votes Catherine D. Rice 71,335,167 956,423 175,465 25,352,808”

Bluejay Diagnostics, Inc. shareholders approved Ratification of Wolf & Company, P.C. as the Company’s Independent Registered Public Accounting Firm at the 2024-05-14 meeting.

“Proposal 4. Ratification of Wolf & Company, P.C. as the Company’s Independent Registered Public Accounting Firm - The Company’s stockholders ratified the appointment of Wolf & Company, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024.”

Bluejay Diagnostics, Inc. shareholders approved Approval of an Amendment to the Company’s Certificate of Incorporation to Effect a Reverse Stock Split at the 2024-05-14 meeting.

“Proposal 3. Approval of an Amendment to the Company’s Certificate of Incorporation to Effect a Reverse Stock Split - The Company’s stockholders approved and adopted an amendment to the Company’s certificate of incorporation to effect a reverse stock split of all of the Company’s outstanding shares of common stock by one of several fixed ratios between 1-for-2 and 1-for-10 (the “Reverse Stock Split”), with the final decision of whether to proceed with the Reverse Stock Split, the effective time of the Reverse Stock Split, and the exact ratio of the Reverse Stock Split to be determined in the future by the Company’s board of directors, in its sole discretion and without further action by the Company’s stockholders.”

Bluejay Diagnostics, Inc. shareholders approved Approval of an Amendment to the Company’s Certificate of Incorporation to Increase the Number of Authorized Shares of Common Stock at the 2024-05-14 meeting.

“Proposal 2. Approval of an Amendment to the Company’s Certificate of Incorporation to Increase the Number of Authorized Shares of Common Stock - The Company’s stockholders approved and adopted an amendment to the Company’s certificate of incorporation to increase the number of authorized shares of the Company’s common stock.”

Bluejay Diagnostics, Inc. shareholders approved Election of directors at the 2024-05-14 meeting.

“Proposal 1. Election of Directors - The Company’s stockholders re-elected each of Donald Chase, Neil Dey, Svetlana Dey, Fred Zeidman, Gary Gemignani and Douglas Wurth to serve as directors until the 2025 Annual Meeting of Stockholders, or until their successors are duly elected and qualified.”

Altair Engineering Inc. shareholders approved Ratification of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2024 at the 2024-05-16 meeting.

“The proposal to ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the Company's fiscal year ending December 31, 2024 was approved by the stockholders based upon the following votes: FOR AGAINST ABSTAIN BROKER NON-VOTES 315,109,024 93,303 20,247 N/A”

Altair Engineering Inc. shareholders approved Advisory vote on compensation of named executive officers at the 2024-05-16 meeting.

“The votes were cast as follows with respect to the proposal to vote, on an advisory basis, on the compensation of the Company's named executive officers as described in the Company's Definitive Proxy Statement: FOR AGAINST ABSTAIN BROKER NON-VOTES 302,379,755 6,077,980 14,598 6,750,241”

Altair Engineering Inc. shareholders approved Election of Mary Boyce and Jim F. Anderson as Class I directors at the 2024-05-16 meeting.

“The stockholders elected nominees Mary Boyce and Jim F. Anderson as Class I directors of the Company to serve a three-year term expiring at the 2027 annual meeting and until the director's successor has been duly elected and qualified, or, if sooner, until the director's death, resignation or removal. The votes were cast with respect to this matter as follows: FOR WITHHOLD BROKER NON-VOTES Mary Boyce 292,084,036 16,388,297 6,750,241 Jim F. Anderson 292,556,775 15,915,558 6,750,241”

MainStreet Bancshares, Inc. shareholders approved Approval of 2019 Equity Incentive Plan at the 2024-05-15 meeting.

“The Board of Directors adopted, subject to shareholder approval, the 2019 Equity Incentive Plan”

MainStreet Bancshares, Inc. shareholders approved increase the number of shares of authorized common stock from 650,000 to 1,150,000 shares at the 2024-05-15 meeting.

“l Meeting of shareholders held on May 15, 2024, the Company's common shareholders approved a proposal to increase the number of shares of authorized common stock from 650,000 to 1,150,000 shares.”

Baker Hughes Co shareholders approved Modernization Proposal (amend charter to clarify and modernize) at the 2024-05-13 meeting.

“The number of votes for, against, abstentions and broker non-votes with respect to the Modernization Proposal was as follows: Number of Votes FOR Number of Votes AGAINST Abstain Votes Broker Non-Votes 861,093,814 4,201,688 437,465 39,134,731”

Baker Hughes Co shareholders approved Federal Forum Proposal (amend charter to add federal forum selection provision) at the 2024-05-13 meeting.

“The number of votes for, against, abstentions and broker non-votes with respect to the Federal Forum Proposal was as follows: Number of Votes FOR Number of Votes AGAINST Abstain Votes Broker Non-Votes 783,006,056 82,244,591 482,319 39,134,731”

Baker Hughes Co shareholders approved Officer Exculpation Proposal (amend charter to limit officer liability) at the 2024-05-13 meeting.

“The number of votes for, against, abstentions and broker non-votes with respect to the Officer Exculpation Proposal was as follows: Number of Votes FOR Number of Votes AGAINST Abstain Votes Broker Non-Votes 745,339,947 119,975,606 417,413 39,134,731”

Baker Hughes Co shareholders approved Ratification of KPMG LLP as independent registered public accounting firm for fiscal year 2024 at the 2024-05-13 meeting.

“The number of votes for, against, abstentions and broker non-votes with respect to the ratification of KPMG LLP as the Company’s Independent Registered Public Accounting Firm for fiscal year 2024 was as follows: Number of Votes FOR Number of Votes AGAINST Abstain Votes Broker Non-Votes 900,500,841 1,888,100 2,478,756 —”

Baker Hughes Co shareholders approved Advisory vote on executive compensation program at the 2024-05-13 meeting.

“The number of votes for, against, abstentions and broker non-votes with respect to the advisory vote related to the Company’s executive compensation program was as follows: Number of Votes FOR Number of Votes AGAINST Abstain Votes Broker Non-Votes 822,360,176 41,410,692 1,962,098 39,134,731”

FVCBankcorp, Inc. shareholders approved Ratification of Yount, Hyde & Barbour, P.C. as independent registered public accounting firm for 2024 at the 2024-05-15 meeting.

“as the Company’s independent registered public accounting firm to audit the financial statements of the Company for the year ended December 31, 2024: For Against Abstain 14,759,061 61,013 18,449 There have been no settlements between the Company and any other person with respect to terminating any solicitation.”

FVCBankcorp, Inc. shareholders approved Advisory vote on frequency of say-on-pay votes (every 1, 2, or 3 years) at the 2024-05-15 meeting.

“To approve, in an advisory (non binding) vote whether an advisory vote on the executive compensation should be held every one, two or three years 1 Year 2 Years 3 Years Abstain 10,697,061 350,743 381,275 119,174 4. Proposal to ratify the appointment of Yount, Hyde & Barbour, P.C. as the Company’s independent registered public accounting firm to audit the financial statements of the Company for the year ended December 31, 2024: For Against Abstain 14,759,061 61,013 18,449 There have been no settlements between the Company and any other person with respect to terminating any solicitation.”

FVCBankcorp, Inc. shareholders approved Advisory approval of named executive officer compensation as disclosed in the proxy statement at the 2024-05-15 meeting.

“ng (non-binding) resolution: Resolved, that the shareholders of FVCBankcorp, Inc., approve the compensation of the named executive officers as disclosed in the proxy statement pursuant to the rules of the Securities and Exchange Commission For Against Abstain 11,015,188 471,276 61,789 3. To approve, in an advisory (non binding) vote whether an advisory vote on the executive compensation should be held every one, two or three years 1 Year 2 Years 3 Years Abstain 10,697,061 350,743 381,275 119,174 4.”

FVCBankcorp, Inc. shareholders approved Election of directors for a one year term expiring at the 2025 Annual Meeting of Shareholders at the 2024-05-15 meeting.

“1. T o elect directors of the Company for a one year term, expiring at the 2025 Annual Meeting of Shareholders: For Withhold David W. Pijor 11,396,090 152,163”

Alcoa Corp shareholders rejected Non-binding stockholder proposal requesting preparation of an annual report on lobbying activities at the 2024-05-10 meeting.

“Item 4 . The non-binding stockholder proposal requesting the preparation of an annual report on lobbying activities was not approved based upon the following votes: For Against Abstentions Broker Non-Votes 42,653,015 75,037,359 1,321,393 19,637,437”

Alcoa Corp shareholders approved Approve, on an advisory basis, 2023 named executive officer compensation at the 2024-05-10 meeting.

“Item 3 . The proposal to approve, on an advisory basis, Alcoa’s 2023 named executive officer compensation was approved based upon the following votes: For Against Abstentions Broker Non-Votes 114,922,468 3,024,575 1,064,724 19,637,437”

Alcoa Corp shareholders approved Ratify appointment of PricewaterhouseCoopers LLP as independent auditor for 2024 at the 2024-05-10 meeting.

“Item 2 . The proposal to ratify the appointment of PricewaterhouseCoopers LLP as Alcoa’s independent auditor for 2024 was approved based upon the following votes: For Against Abstentions Broker Non-Votes 136,098,587 762,818 1,787,799 0”

Alcoa Corp shareholders approved Election of 10 director nominees at the 2024-05-10 meeting.

“Item 1 . The 10 director nominees nominated by the Alcoa Board of Directors (the “Board”) for election to the Board were elected, each for a one-year term, based upon the following votes: Nominee For Against Abstentions Broker Non-Votes”